The vast majority of people who receive this vaccine have mild or no side effects.
The chief infectious disease expert reported on Sunday that the United States will take steps in the next few days to resume the use of Johnson & Johnson’s COVID-19 vaccine. After some very rare cases of blood clots have been reported, there may be broader restrictions or warnings.
Dr. Anthony Fauci said in a series of interviews on news programs that once consultants from the Centers for Disease Control and Prevention (CDC) meet on Friday, they will decide whether to resume the Johnson & Johnson single-dose vaccine.
He said: “If we didn’t have some form of resume before Friday, I would be very surprised.” “I really didn’t expect them to want to expand a bit.”
Fauci is the chief medical adviser to President Joe Biden. He believes that federal regulators can resume vaccine use with age or gender restrictions or blanket warnings, and the way it is used is “compared to before.” It’s different. Rest”.
After the CDC and the U.S. Food and Drug Administration (FDA) said last week that they need more evidence to determine whether certain blood clots are related to injections, and if the risk of this happens, Johnson & Johnson’s vaccine Has been at a standstill. .
These cases are unusual: out of more than 7 million Johnson & Johnson vaccine injections, 6 have been reported. Blood clots were found in six women between the ages of 18 and 48. One person died.
Tuesday’s decision triggered swift action in Europe and other regions.
Fauci said he seriously doubts that the United States will permanently stop using Johnson & Johnson vaccine.
He said: “I don’t think this will happen.” “The break is to take a look to make sure we know all the information we might have in this time frame, and to warn some people who might see this particular adverse event ( Especially female) doctors, treat them correctly”.
The vast majority of people who receive this vaccine have almost no side effects. The authorities emphasized that they have not found signs of clot problems in the most commonly used COVID-19 vaccines in the United States (namely Moderna and Pfizer).
NBC’s “Media Meeting”, CNN’s “State of the Union Address”, ABC’s “This Week” and CBS’s “Country Facing”.